The latest results stated that "more than 90%" patients...

The latest results stated that "more than 90%" patients benefitted. The more than 90% sounds great but in order for it to be approved by FDA, results need to show = to or greater than 95%. Phase 1 was above this, price hit $1.10 Phase 2 was a bit less and all of a sudden a trend in the results is possibly occuring.

Whoever writes the announcements is a very good marketeer with a positive tone despite the underlying facts painting a different picture. Here's hoping results in Phase 3 pick up but it is a big ask. Good luck holders.